A judge has dismissed charges against a Filipino doctor accused of defrauding the U.S. military's healthcare program by submitting $2 million worth of bogus claims, saying prosecutors waited too long to arrest him after filing charges. U.S. District Judge Barbara Crabb ruled that Diogenes Dionisio, MD's constitutional right to a speedy trial was violated because investigators waited four years to arrest him after his 2004 indictment.
After a Senate inquiry found evidence of deceptive marketing, the AARP has hired an outside investigator to look into sales of some of its popular health insurance products. AARP and UnitedHealth Group have voluntarily suspended sales of the policies, which pay fixed cash benefits for selected services.
Sen. Hillary Rodham Clinton, considered a prominent contender to become secretary of State in the Obama administration, was offered to be a senior member of the Senate team aiming to overhaul the nation's healthcare system. Sen. Edward M. Kennedy, who has announced plans to craft sweeping healthcare legislation, asked Clinton to head a working group focused on insurance coverage.
The potential assignment comes a decade and a half after Clinton led a controversial, and ultimately failed, effort to reshape the healthcare system as first lady during her husband's first term in the White House.
If Pennsylvania's insurance commissioner decides to approve the proposed merger between Independence Blue Cross and Highmark Inc., he should impose a raft of conditions designed to limit their market power, says the Republican-led Senate Banking and Insurance Comittee in draft resolutions scheduled to come for a committee vote. The decision on whether to approve the merger rests with Commissioner Joel Ario alone. But the committee has lots of opinions on what Ario should do, starting with a plea that he reject it.
In 2007, after news broke that the diabetes drug Avandia was linked to a high risk of heart attacks, reports that the drug's maker had tried to stifle safety questions from a prominent Duke University researcher years earlier provoked a furor. Now it turns out that the Duke researcher wasn't alone in suggesting a tie to heart problems. A doctor from a small Maryland hospital linked Avandia to congestive heart failure in 2000, but the drug's maker, GlaxoSmithKline PLC, rejected her warning and tried to make her stop talking about it with other doctors and hospitals.
The uninsured, tort reform, and the nursing shortage matter, but obesity matters a lot more, according to a group of CEOs that met to hash out what they thought the president-elect's top health priorities should be. The group—which included the CEOs of Pfizer, Novartis, WellPoint and the Mayo Clinic—is part of the WSJ CEO Council, a conference the Wall Street Journal convened in Washington, DC. The looming disease burden associated with the obesity epidemic, and all the costs and suffering it will entail, apparently pushed it ahead of other, frequently discussed health-reform issues.